Eduardo Nava studied at the Autonoma University of Madrid, Spain, where he completed his degree in Medicine as well as a PhD and worked as a post-doc. After moving to London, England in 1990 and researching as a post-doctoral Fellow within the framework of the Wellcome Trust for Biomedicine, he moved to Switzerland in 1993 and was employed under Professor Thomas F. Lüscher at the University Hospital Berne. In 1995 he returned to Spain at the University of Mucia. Dr. Nava researched in the field of the biology of nitric oxide in hypertension, aging and septic shock, as well as the effect of glitazones on macrovascular and microvascular function in hypertension.
In 1999 Dr. Nava was appointed as Associate Professor at the University of Castilla-La Mancha in Spain and Lecturer in Physiology.
His current research activates include the role of perivascular adipose tissue in microvascular function in metabolic syndrome, as well as the effects of glitazones.